Cancer52/PHE Event: Development in Data for Rare and Less Common Cancers

By Leanne Talbot

Posted 7 years ago

23/07/2019 2pm

On the 22nd May, Cancer52 and PHE/NCRAS held an event focussed on the Developments in Data for Rare and Less Common Cancers. Tracey Genus presented NPF and PHE’s dataset for Neuroendocrine Cancers at the event. 

Lucy Elliss-Brookes, Head of Cancer Analysis at Public Health England said “There was a real buzz in the room throughout the event, with a wide range of people coming together to share and learn about rare and less common cancers. My personal highlight was the patients’ support for the work that we are doing with their data, they could really see that by bringing teams together we can collectively achieve so much more with the data that we work hard to collect and analyse.”

[npfButton size=“small” text=”Find out more” href=”https://www.cancer52.org.uk/single-post/2019/07/17/Summary-of-Cancer52-PHE-Event-Development-in-Data-for-Rare-and-Less-Common-Cancers” background-colour=”#f06124″ text-colour=”#ffffff”]

Catch up on the latest news, stories and updates

Ongoing variability in the supply of pancreatic enzyme replacement therapy (PERT) — particularly Creon® 25,000iu capsules — has left some people struggling to obtain their prescription. ...